annual cash & cash equivalents:
$320.56M+$44.72M(+16.21%)Summary
- As of today (September 10, 2025), RYTM annual cash & cash equivalents is $320.56 million, with the most recent change of +$44.72 million (+16.21%) on December 31, 2024.
- During the last 3 years, RYTM annual cash & cash equivalents has risen by +$25.71 million (+8.72%).
- RYTM annual cash & cash equivalents is now -3.82% below its all-time high of $333.29 million, reached on December 31, 2022.
Performance
RYTM Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$291.03M-$23.46M(-7.46%)Summary
- As of today (September 10, 2025), RYTM quarterly cash & cash equivalents is $291.03 million, with the most recent change of -$23.46 million (-7.46%) on June 30, 2025.
- Over the past year, RYTM quarterly cash & cash equivalents has dropped by -$28.10 million (-8.81%).
- RYTM quarterly cash & cash equivalents is now -28.10% below its all-time high of $404.75 million, reached on March 31, 2021.
Performance
RYTM quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RYTM Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.2% | -8.8% |
| 3 y3 years | +8.7% | +23.5% |
| 5 y5 years | +9.6% | +27.3% |
RYTM Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.8% | +16.2% | -16.3% | +44.6% |
| 5 y | 5-year | -3.8% | +85.5% | -28.1% | +68.4% |
| alltime | all time | -3.8% | >+9999.0% | -28.1% | >+9999.0% |
RYTM Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $291.03M(-7.5%) |
| Mar 2025 | - | $314.49M(-1.9%) |
| Dec 2024 | $320.56M(+16.2%) | $320.56M(+7.4%) |
| Sep 2024 | - | $298.39M(-6.5%) |
| Jun 2024 | - | $319.13M(+58.6%) |
| Mar 2024 | - | $201.20M(-27.1%) |
| Dec 2023 | $275.85M(-17.2%) | $275.85M(-7.8%) |
| Sep 2023 | - | $299.26M(+18.0%) |
| Jun 2023 | - | $253.60M(-13.9%) |
| Mar 2023 | - | $294.58M(-11.6%) |
| Dec 2022 | $333.29M(+13.0%) | $333.29M(-4.2%) |
| Sep 2022 | - | $347.80M(+47.6%) |
| Jun 2022 | - | $235.60M(-2.2%) |
| Mar 2022 | - | $240.96M(-18.3%) |
| Dec 2021 | $294.86M(+70.6%) | $294.86M(-10.2%) |
| Sep 2021 | - | $328.35M(-10.8%) |
| Jun 2021 | - | $368.15M(-9.0%) |
| Mar 2021 | - | $404.75M(+134.2%) |
| Dec 2020 | $172.79M | $172.79M(-14.4%) |
| Sep 2020 | - | $201.78M(-11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $228.63M(-11.2%) |
| Mar 2020 | - | $257.42M(-12.0%) |
| Dec 2019 | $292.46M(+16.0%) | $292.46M(+80.0%) |
| Sep 2019 | - | $162.44M(-16.8%) |
| Jun 2019 | - | $195.17M(-11.9%) |
| Mar 2019 | - | $221.52M(-12.1%) |
| Dec 2018 | $252.06M(+70.2%) | $252.06M(-7.5%) |
| Sep 2018 | - | $272.39M(-5.3%) |
| Jun 2018 | - | $287.55M(+110.7%) |
| Mar 2018 | - | $136.45M(-7.9%) |
| Dec 2017 | $148.08M(+1305.4%) | $148.08M(+386.9%) |
| Sep 2017 | - | $30.41M(+71.4%) |
| Jun 2017 | - | $17.74M(-25.7%) |
| Mar 2017 | - | $23.88M(-31.5%) |
| Dec 2016 | $10.54M(-69.8%) | - |
| Dec 2015 | $34.87M(>+9900.0%) | - |
| Dec 2015 | - | $34.87M(>+9900.0%) |
| Dec 2014 | $152.00K(-99.1%) | $152.00K(-98.4%) |
| Jun 2014 | - | $9.33M |
| Dec 2013 | $17.76M(+4.3%) | - |
| Dec 2012 | $17.04M | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of RYTM is $320.56M
What is the all time high annual cash & cash equivalents for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual cash & cash equivalents is $333.29M
What is Rhythm Pharmaceuticals, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, RYTM annual cash & cash equivalents has changed by +$44.72M (+16.21%)
What is Rhythm Pharmaceuticals, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RYTM is $291.03M
What is the all time high quarterly cash & cash equivalents for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly cash & cash equivalents is $404.75M
What is Rhythm Pharmaceuticals, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, RYTM quarterly cash & cash equivalents has changed by -$28.10M (-8.81%)